These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26332140)

  • 1. Foresight Study on the Risk Governance of New Technologies: The Case of Nanotechnology.
    Read SA; Kass GS; Sutcliffe HR; Hankin SM
    Risk Anal; 2016 May; 36(5):1006-24. PubMed ID: 26332140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding 'anticipatory governance'.
    Guston DH
    Soc Stud Sci; 2014 Apr; 44(2):218-42. PubMed ID: 24941612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steering vaccinomics innovations with anticipatory governance and participatory foresight.
    Ozdemir V; Faraj SA; Knoppers BM
    OMICS; 2011 Sep; 15(9):637-46. PubMed ID: 21848419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering imaginaries: Anticipatory foresight for solar radiation management governance.
    Low S
    Sci Total Environ; 2017 Feb; 580():90-104. PubMed ID: 28011016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.
    Nelson KC; Andow DA; Banker MJ
    J Law Med Ethics; 2009; 37(4):732-48. PubMed ID: 20122113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demand for command: responding to technological risks and scientific uncertainties.
    Stokes E
    Med Law Rev; 2013; 21(1):11-38. PubMed ID: 23329016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream oversight assessment for agrifood nanotechnology: a case studies approach.
    Kuzma J; Romanchek J; Kokotovich A
    Risk Anal; 2008 Aug; 28(4):1081-98. PubMed ID: 18627547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk analysis and technology assessment in support of technology development: Putting responsible innovation in practice in a case study for nanotechnology.
    van Wezel AP; van Lente H; van de Sandt JJ; Bouwmeester H; Vandeberg RL; Sips AJ
    Integr Environ Assess Manag; 2018 Jan; 14(1):9-16. PubMed ID: 28901636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Imagining the Futures of Implementation Precision Medicine Using Scenario Analysis and Design Fiction.
    York E; Conley SN; Henriksen AD; Caserta D; Etka N; Harrington N; Jennings M; Kodua S; Pates R; Sevison Z; Terry E; VanNostrand S; Vargas K
    OMICS; 2019 Jul; 23(7):340-349. PubMed ID: 31161960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.
    Kuzma J; Najmaie P; Larson J
    J Law Med Ethics; 2009; 37(4):546-86. PubMed ID: 20122100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological innovation, human capital and social change for sustainability. Lessons learnt from the industrial technologies theme of the EU's Research Framework Programme.
    Sabadie JA
    Sci Total Environ; 2014 May; 481():668-73. PubMed ID: 24149071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology, risk, and oversight: learning lessons from related emerging technologies.
    Kuzma J; Priest S
    Risk Anal; 2010 Nov; 30(11):1688-98. PubMed ID: 20723152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using strategic foresight to assess conservation opportunity.
    Cook CN; Wintle BC; Aldrich SC; Wintle BA
    Conserv Biol; 2014 Dec; 28(6):1474-83. PubMed ID: 25381735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Biology in the FDA Realm: Toward Productive Oversight Assessment.
    Fatehi L; Hall RF
    Food Drug Law J; 2015; 70(2):339-69, iii-iv. PubMed ID: 26302603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsible, Inclusive Innovation and the Nano-Divide.
    Schroeder D; Dalton-Brown S; Schrempf B; Kaplan D
    Nanoethics; 2016; 10():177-188. PubMed ID: 27478517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Devices of Responsibility: Over a Decade of Responsible Research and Innovation Initiatives for Nanotechnologies.
    Shelley-Egan C; Bowman DM; Robinson DKR
    Sci Eng Ethics; 2018 Dec; 24(6):1719-1746. PubMed ID: 29019058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and risk governance in unconventional shale gas development.
    Small MJ; Stern PC; Bomberg E; Christopherson SM; Goldstein BD; Israel AL; Jackson RB; Krupnick A; Mauter MS; Nash J; North DW; Olmstead SM; Prakash A; Rabe B; Richardson N; Tierney S; Webler T; Wong-Parodi G; Zielinska B
    Environ Sci Technol; 2014; 48(15):8289-97. PubMed ID: 24983403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.